30th Hemophilia Symposium Hamburg 1999

1. Front Matter

   Pages I-XXXIV

   PDF

2. HIV Infection and Epidemiology in Hemophilia

   1. Front Matter

      Pages 1-1

      PDF

   2. Causes of Death and AIDS-Related Disease in Hemophilia Patients in Germany (Inquiries 1999)

      • W. Schramm, H. Krebs, S. Fleissner

      Pages 3-10

3. Gene Therapy in Hemophilia

   1. Front Matter

      Pages 11-11

      PDF

   2. Genotype-Phenotype Correlation in Hemophilia A

      • J. Graw, H.-H. Brackmann, J. Oldenburg, W. Schramm, R. Schwaab

      Pages 13-21

4. Therapy of Hepatitis C

   1. Front Matter

      Pages 23-23

      PDF

   2. Current Therapy of Hepatitis C Virus Infection

      • H. M. Diepolder

      Pages 25-31

   3. Interferon Alpha-2a Treatment in Patients with Hepatitis C and Bleeding Disorders

      • R. Zimmermann, A. Huth-Kühne, A. Skibbe, P. Lages, T. Göser

      Pages 32-34

   4. Report on Experience in the Treatment of Hepatitis C in HIV-Coinfected Hemophiliacs

      • J. K. Rockstroh

      Pages 35-41

5. Inhibitors in Hemophilia

   1. Front Matter

      Pages 43-43

      PDF

   2. A New Therapeutic Option for Inhibitor Elimination in Patients with Acquired Hemophilia

      • A. Huth-Kühne, P. Lages, R. Zimmermann

      Pages 45-52

6. Long-Term Results After Joint Replacement

   1. Front Matter

      Pages 53-53

      PDF

   2. Long-Term Results After Total Knee and Total Hip Replacement in Hemophilic Arthropathy

      • L. Hovy, S. Müller, I. Scharrer

      Pages 55-61

   3. Total Knee Prosthesis in Hemophiliacs with Multilocular Hemophilic Arthropathy — The Zurich Experience

      • E. O. Meili, M. Rodriguez

      Pages 62-64

   4. Corrective Osteotomy of the Lower Extremity in Hemophilic Arthropathy of the Knee and Hip Joint

      • T. Wallny, H. H. Brackmann, L. Hess, H. Reich, A. Seuser

      Pages 65-70

7. Pediatric Hemostasiology

   1. Front Matter

      Pages 71-71

      PDF

   2. Anticoagulant Action of Activated Protein C is Diminished by Alpha2-Macroglobulin in Newborn Plasma

      • G. Cvirn, S. Gallistl, J. Kutschera, W. Muntean

      Pages 73-85

   3. Functional Consequences of Differences in Carbohydrate Sequences of Fetal and Adult Plasminogen and Fibrinogen

      • M. Ries, R. Easton, M. Zenker, C. Longstaff, A. Dell, R. J. Gaffney

      Pages 86-101

   4. Hereditary Thrombophilic Risk Profiles in Children with Spontaneous Venous Thromboembolism

      • A. Kosch, R. Junker, K. Auberger, R. Schobess, H.-G. Koch, U. Nowak-Göttl

      Pages 102-109

   5. Inhibitor Development in Previously Untreated Patients with Hemophilia A and B: A Prospective 23-Year Follow-Up

      • C. Escuriola Ettingshausen, A. Zyschka, J. Oldenburg, I. Martinez Saguer, S. Ehrenforth, W. Kreuz

      Pages 110-113

This book contains the contributions to the 30th Hemophilia Symposium, 1999. The main topics are HIV infection, inhibitors in hemophilia, modern treatment of hemophilia, drug-induced thrombophilia and pediatric hemostasiology. The volume is rounded off by numerous free papers and posters on hemophilia and associated topics.

• HIV
• HIV infection
• epidemiology
• gene therapy
• hemophilia
• hepatitis C infection
• infection
• pediatric hemostaseology
• v. Willebrand's disease

• Hemophilia Center, Dept. of Internal Medicine, University Hospital, Frankfurt am Main, Germany

  Inge Scharrer

• Dept. of Hemostasiology, University Hospital, München, Germany

  Wolfgang Schramm

Policies and ethics